The drug Todacitan has been available in Spain since 2021, although on February 1, Social Security began financing it with the aim of reducing tobacco consumption, which is the main cause of preventable premature death in Spain. More than 53,000 people die every year in our country from using tobacco. Todacitan has as its active ingredient cytistin, a plant alkaloid that has almost the same effects as nicotine, as both bind to the same receptor in the brain, acting more pleasantly than nicotine itself. On the other hand, this substance prevents nicotine from binding to those receptors in the brain. It is proven that todacitan helps reduce the desire to smoke in the individual, since an effic... [Read more]